Why early participant engagement is now a top priority in genetic disease research
pharmaphorum
JANUARY 18, 2023
In our experience of running 20+ precision medicine studies, there are a few design principles that every research programme – from biobanks to clinical trials – should consider. And if participants have opted in to be made aware of their risks of genetic diseases, then communication has to be carefully considered.
Let's personalize your content